BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong RJ, Kachru N, Martinez DJ, Moynihan M, Ozbay AB, Gordon SC. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. J Clin Gastroenterol 2021;55:891-902. [PMID: 32815873 DOI: 10.1097/MCG.0000000000001409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hwang TI, Han AL. Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease. Int J Environ Res Public Health 2021;18:13145. [PMID: 34948754 DOI: 10.3390/ijerph182413145] [Reference Citation Analysis]
2 Martinez-castillo M, León-mancilla B, Ramírez-rico G, Alfaro A, Pérez-torres A, Díaz-infante D, García-loya J, Medina-avila Z, Sanchez-hernandez J, Piña-barba C, Gutierrez-reyes G. Xenoimplant of Collagen Matrix Scaffold in Liver Tissue as a Niche for Liver Cells. Front Med 2022;9:808191. [DOI: 10.3389/fmed.2022.808191] [Reference Citation Analysis]
3 Martinez-Urbistondo D, Suarez Del Villar R, Argemí J, Daimiel L, Ramos-López O, San-Cristobal R, Villares P, Martinez JA. Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. Antioxidants (Basel) 2020;9:E1125. [PMID: 33202851 DOI: 10.3390/antiox9111125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gracen L, Hayward KL, Aikebuse M, Russell A, O'Beirne J, McPhail S, Irvine KM, Williams S, Valery PC, Powell EE. Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes. BMC Health Serv Res 2022;22:487. [PMID: 35413987 DOI: 10.1186/s12913-022-07808-7] [Reference Citation Analysis]